Novel therapies create potential new options for patients with advanced breast cancer
Cancer · 01.11.2026 · 132 (21)
DOI: 10.1002/cncr.70619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 03.11.2026. Verfasst von Leah Lawrence. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
This news section offers Cancer readers timely information on events, public policy analysis, and topical issues. In this issue, first‐line sacituzumab govitecan plus pembrolizumab may improve long‐term outcomes for patients with advanced triple‐negative breast cancer, whereas the new CDK4/6 inhibitor fovinaciclib shows promising efficacy. In addition, decade‐long CAR T‐cell data indicate durable disease control and potential cure, and telehealth tobacco cessation doubles quit rates in patients with cancer.
Zitieren
APA
Lawrence, L. (2026). Novel therapies create potential new options for patients with advanced breast cancer. Cancer, 132(21). https://doi.org/10.1002/cncr.70619
Vancouver
Lawrence L. Novel therapies create potential new options for patients with advanced breast cancer. Cancer. 2026;132(21). doi:10.1002/cncr.70619
BibTeX
@article{Lawrence2026,
author = {Lawrence, Leah},
title = {Novel therapies create potential new options for patients with advanced breast cancer},
journal = {Cancer},
year = {2026},
volume = {132},
number = {21},
doi = {10.1002/cncr.70619}
}
EUVIMED